NMDA glutamate receptor antagonist MK ‐801 induces proteome changes in adult human brain slices which are partially counteracted by haloperidol and clozapine
Journal of Neurochemistry · 2024
DOI: 10.1111/jnc.16059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurochemistry, 2024. Verfasst von Valéria de Almeida und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neuroproteomics, Department of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas (UNICAMP), Campinas, Brazi…. Hauptthemen laut MEDLINE: Clozapine, Antipsychotic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 83 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado de São Paulo, Instituto Serrapilheira.
Abstract (Originalsprache)
Deciphering the molecular pathways associated with N‐methyl‐D‐aspartate receptor (NMDAr) hypofunction and its interaction with antipsychotics is necessary to advance our understanding of the basis of schizophrenia, as well as our capacity to treat this disease. In this regard, the development of human brain‐derived models that are amenable to studying the neurobiology of schizophrenia may contribute to filling the gaps left by the widely employed animal models. Here, we assessed the proteomic changes induced by the NMDA glutamate receptor antagonist MK‐801 on human brain slice cultures obtained from adult donors submitted to respective neurosurgery. Initially, we demonstrated that MK‐801 diminishes NMDA glutamate receptor signaling in human brain slices in culture. Next, using mass‐spectrometry‐based proteomics and systems biology in silico analyses, we found that MK‐801 led to alterations in proteins related to several pathways previously associated with schizophrenia pathophysiology, including ephrin, opioid, melatonin, sirtuin signaling, interleukin 8, endocannabinoid, and synaptic vesicle cycle. We also evaluated the impact of both typical and atypical antipsychotics on MK‐801‐induced proteome changes. Interestingly, the atypical antipsychotic clozapine showed a more significant capacity to counteract the protein alterations induced by NMDAr hypofunction than haloperidol. Finally, using our dataset, we identified potential modulators of the MK‐801‐induced proteome changes, which may be considered promising targets to treat NMDAr hypofunction in schizophrenia. This dataset is publicly available and may be helpful in further studies aimed at evaluating the effects of MK‐801 and antipsychotics in the human brain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Neuroproteomics, Department of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas (UNICAMP), Campinas, Brazil.
- Department of Biochemistry and Immunology, Ribeirao Preto Medical School, University of Sao Paulo, Sao Paulo, Brazil.
- Department of Pathology and Forensic Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Sao Paulo, Brazil.
- Division of Neurosurgery, Department of Surgery and Anatomy, Ribeirão Preto Medical School, University of São Paulo, Sao Paulo, Brazil.
- Instituto Nacional de Biomarcadores em Neuropsiquiatria (INBION) Conselho Nacional de Desenvolvimento Científico e Tecnológico, Sao Paulo, Brazil.
- Experimental Medicine Research Cluster (EMRC), University of Campinas, Campinas, Sao Paulo, Brazil.
ORCID-Profile: Giuliana S Zuccoli, Adriano Sebollela
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Instituto Serrapilheira
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Apoio ao Ensino, Pesquisa e Assistência do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
Zitieren
APA
de Almeida, V., Mendes, N. D., Zuccoli, G. S., Reis-de-Oliveira, G., Almeida, G. M., Podolsky-Gondim, G. G., Neder, L., Martins-de-Souza, D., & Sebollela, A. (2024). NMDA glutamate receptor antagonist MK ‐801 induces proteome changes in adult human brain slices which are partially counteracted by haloperidol and clozapine. Journal of Neurochemistry. https://doi.org/10.1111/jnc.16059
Vancouver
de Almeida V, Mendes ND, Zuccoli GS, Reis-de-Oliveira G, Almeida GM, Podolsky-Gondim GG, et al. NMDA glutamate receptor antagonist MK ‐801 induces proteome changes in adult human brain slices which are partially counteracted by haloperidol and clozapine. Journal of Neurochemistry. 2024. doi:10.1111/jnc.16059
BibTeX
@article{deAlmeida2024,
author = {de Almeida, Valéria and Mendes, Niele Dias and Zuccoli, Giuliana S and Reis-de-Oliveira, Guilherme and Almeida, Glaucia M and Podolsky-Gondim, Guilherme Gozzoli and Neder, Luciano and Martins-de-Souza, Daniel and Sebollela, Adriano},
title = {NMDA glutamate receptor antagonist MK ‐801 induces proteome changes in adult human brain slices which are partially counteracted by haloperidol and clozapine},
journal = {Journal of Neurochemistry},
year = {2024},
doi = {10.1111/jnc.16059}
}
EUVIMED